Alnylam Pharmaceuticals
ALNY
#453
Rank
S$66.76 B
Marketcap
S$505.35
Share price
-5.16%
Change (1 day)
48.06%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company